Summary: AXIM places strategic focus on commercializing FDA-cleared Dry Eye Disease (DED) diagnostic systemPlans to address largely underserved DED diagnosis…
SOMERVILLE, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage…
DENVER, April 19, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative…
WALTHAM, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) today announced its participation in the Jefferies Biotech on…
Market access improves with approximately 5 million people in the Texas Medicaid patient networkSOLANA BEACH, Calif., April 19, 2022 (GLOBE…
New agreement with the fastest-growing veterinary telehealth and pet-care marketplace provides 24/7 access to over 70,000 veterinarians for PetMeds®’ millions…
Expects to Report Results of Independent Data Monitoring Committee (IDMC) Mandated Interim Safety Reviews and Interim Efficacy Review in the…
Dr. El-Gabry’s extensive leadership experience will be critical to accelerating Akoya’s groundbreaking spatial biomarker research technologies into clinical tools that…
Accomplished business executive and attorney with diverse industry experience including over 20 years in life sciences and pharma with successful…
– Strengthens intellectual property portfolio for macimorelin and the commercial product Ghryvelin®/ Macrilen™in Europe as the Company plans to pursue…